CD27 cooperates with the pre-T cell receptor in the regulation of murine T cell development by unknown
CD27  Cooperates  with the Pre-T  Cell Receptor  in the 
Regulation  of Murine T  Cell Development 
By Loes A. Gravestein,* Willem van Ewijk,* Ferry Ossendorp,g 
and Jannie Borst* 
From the *Division of Cellular Biochemistry, The Netherlands  Cancer Institute,  1066 CX, 
Amsterdam; *,Department of Immunology, Erasmus University, 3000 DR Rotterdam; and 
~  Department  of lmmunohaematology, Academic Hospital Leiden, 2333 AA Leiden, The Netherlands 
Summary 
CD27  is a lymphocyte-specific member of the  TNF receptor family and has a  TNF-related 
transmembrane  ligand,  CD70.  The  CD27/CD70  receptor-ligand  pair  cooperates  with  the 
TCR in the regulation of the peripheral T  cell response. The study presented here reveals that 
CD27  may play a similar role in thymic pre-T cell development. We have previously cloned 
the cDNA encoding murine CD27, prepared specific mAbs and observed that murine CD27 is 
expressed on virtually all thymocytes, with the exception of a subpopulation of CD4-8- pre- 
cursor T  cells.  It is shown here that induction of murine CD27 expression occurs at the transi- 
tion from the CD4-8-25 + to the CD4-8-25-  precursor T  cell stage and is regulated by the 
pre-TCR. Therefore, we investigated whether CD27 contributes to pre-TCR-mediated thy- 
mocyte development. Pre-TCR function was mimicked by the induction of CD3 signaling in 
thymocytes of recombination activating gene (RAG)~deficient mice. This in vivo anti-CD3e 
rnAb  treatment induces  an about fifty fold numerical expansion of CD4-8-25 +  thymocytes 
and their differentiation to the CD4+8+25  stage. Co-injection of anti-CD27 nLAb inhibited 
the  CD3-mediated  expansion  and  differentiation  of the  CD4-8-25 +  precursor  population. 
Also, injection of anti-CD27 mAb in TCR{x -/- mutant mice led to a reduction in the absolute 
number of CD4+8+25 -  thymocytes. We present evidence that in these in vivo systems, anti- 
CD27  mAb inhibits CD27-1igand interaction.  Therefore, we conclude  that CD27  may con- 
tribute  to  normal murine  T  cell development by synergizing with  the pre-TCR-mediated 
signal. 
I 
n the murine system, recent thymic immigrants are char- 
acterized by high cell surface levels of the CD44 mole- 
cule  and  lack  of CD4  and  CD8.  Upon  maturation,  thy- 
mocytes acquire  the  CD25  marker and  subsequently lose 
CD44 expression (reviewed in reference 1). The recombi- 
nation  activating  gene  (RAG) 1 products,  which  catalyze 
TCR  gene  rearrangement,  are  crucial  for  further  thy- 
mocyte development: elimination of the RAG-1 or RAG-2 
gene results in lack of TCR protein expression and a con- 
sequent  differentiation  arrest  at  the  CD44-,  CD4-8-25 + 
stage (2, 3).  Introduction of a TCR[$ transgene into RAG- 
deficient mutant mice allows the generation of a wild-type 
sized CD44-, CD4+8+25 -  thymocyte population (4, 5). Pre- 
cursor T  cell proliferation  and  differentiation  at  this  stage 
are mediated by the pre-TCR complex, which  consists of 
the TCRI3 chain, the pTc~ chain and CD3 components (6, 
7).  Pre-TCR function can be mimicked by triggering the 
1Abbreviation used in this paper: RAG, recombination  activating  gene. 
CD3 components expressed on RAG-deficient thymocytes 
with specific mAb.  This treatment induces the generation 
of the CD4+8+25 -  thymic compartment (8-10). 
While the pre-TCR is required for early thymic devel- 
opment, other molecules present on thymocytes and stro- 
mal cells are expected to contribute to the maturation pro- 
cess: cytokines and cytokine receptors controlling proliferation 
and differentiation,  as well as molecules affecting cell sur- 
vival. Members of the TNF receptor family have been im- 
plicated  in  the  regulation  of proliferation  and  differentia- 
tion  of lymphoid cells  (reviewed in reference  11  and  12). 
These receptors have membrane-bound or soluble  TNF- 
related  ligands,  whose  expression  is  tightly  regulated. 
Within the lymphoid system, the function of TNF receptor 
family members CD40  and APO-1/fas  (CD95)  has been 
most extensively studied. CD40 has been detected on some 
stromal  cells  and  B  cells  in  the  human  thymus  (13).  Al- 
though  CD40 -/-  (14)  or  CD40  ligand  -/-  (15)  mutant 
mice have no obvious defects in T  cell  maturation,  treat- 
ment of mice with anti-CD40 ligand mAb influences thymic 
selection (16).  CD95 is essential for the deletion ofperiph- 
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CD95  mutant  lpr mice  or  CD95  ligand mutant gld mice 
have no defects in the deletion of auto-reactive thymocytes 
(18,  19).  Nevertheless,  in  vitro  triggering of CD95  with 
antibodies  can  induce  cell  death  in  CD4+8 §  thymocytes 
(20, 21). 
The lymphocyte-specific members of the TNF receptor 
family CD27  (22), CD30  (23), 4-1BB  (24) and OX40  (25) 
have been shown to affect the outcome of TCR-  and/or B 
cell receptor-induced signal transduction (26-28).  CD27  is 
expressed  on  most  peripheral T  cells in  human  (26)  and 
mouse  (29).  TCR.  triggering on human  peripheral T  cells 
results  in  an  about  fourfold  increase  in  CD27  expression 
within a few days (26). Murine CD27 is not subject to such 
dramatic  upregulation;  it is  already expressed  at  relatively 
high  levels on  resting T  cells  (29).  Anti-CD27  mAb  en- 
hance TCR-induced proliferation of both human  (26) and 
murine  (29)  peripheral T  cells. The antibodies most likely 
induce CD27  function, since interaction of CD27  with its 
ligand (CD70)  on transfected cells has comparable effects: it 
enhances TCP,-induced proliferation of human  peripheral 
blood  T  cells  and  their  differentiation  into  effector  cells 
(30-32).  It remains to be established by which mechanism 
CD27  contributes to peripheral T  cell expansion and  dif- 
ferentiation. 
We  have  previously isolated the  cDNA  encoding mu- 
rine  CD27  (33),  generated  specific  antibodies  to  murine 
CD27  in  Armenian  hamsters  and  found  that  these  mAb, 
upon  cross-linking by second step reagent,  mimic the  ac- 
tion of the CD27  ligand (29).  An inventory of CD27  ex- 
pression in the mouse showed that virtually all thymocytes 
express CD27,  with the exception of a  subset of CD4-8- 
cells  (29).  In  this  paper,  we  focus  on  the  expression  and 
function of CD27  in murine thymocyte development and 
provide evidence that CD27 cooperates with the pre-TCP, 
in  the  induction  of thymocyte  expansion and  differentia- 
tion. 
Materials and Methods 
Mice.  Wild-type mice were from the C57BL/6,  129/O1a or 
BALB/C strains  and used at 4-8 weeks of age. The RAG-1 -/- 
(2) and the TCRo~ -/-  (5) mutant mice were on a nfixed back- 
ground of 129/Ola and SV; both types of mice were 4-6 weeks 
of age when used. 
Antibodies.  Anti-mouse mAb used in  this study were:  anti- 
CD27,  LG.3A10  (29);  anti-CD3e,  145.2Cll  (34)  and  500A2 
(35); anti-TCR~/~, GL-3 (36); anti-FcR.III and -FcyRllb, 2.4G2 
(37);  anti-CD4,  RM4-5;  anti-CD8,  53-6.7;  anti-CD25,  3C7; 
anti-CD45, 30 F11.1  (all from PharMingen, San Diego, CA), and 
5.9  (Ossendorp,  F.,  unpublished results).  For generation  of the 
5.9  mAb,  an  Armenian  hamster  was  immunized  with  murine 
C57BL/6  thymocytes. Hybridomas were generated as described 
(29) and selected for reactivity with murine thymocytes by im- 
munofluorescence  analysis.  The  5.9  mAb reacts with  CD4  8- 
thymocytes, and to a lesser degree with CD4+8 + thymocytes. It 
does not show detectable staining ofCD4 + or CD8 + single posi- 
tive  thymocyte populations or peripheral T  lymphocytes. The 
antibody does react with splenic B  lymphocytes and subpopula- 
tions of bone marrow cells. Immunoprecipitation of the 5.9 anti- 
gen revealed a 20-23-kD protein, that migrates at 16-18-kD un- 
der non-reducing conditions and is sensitive to digestion with PI- 
PLC, indicating that it is anchored in the plasma membrane by a 
phospholipid anchor  (Ossendorp,  F.,  unpublished results).  The 
collected results suggest that the 5.9 mAb recognizes a novel pro- 
tein related to the products of the Ly-6 gene family (38). Normal 
hamster IgG was from Jackson Immuno-kesearch  Laboratories 
lnc. (West Grove, PA). Antibodies used for in vivo experiments 
were purifed from tissue culture supernatant by HPLC using an 
ABX column (Baker, Philipsburg, NJ).  Purified antibodies were 
biotinylated or FITC-labeled according to  standard  procedures 
and dialyzed against PBS. 
In Vivo Antibody Treatment.  Mice were  injected intravenously 
with 50 btg of appropriate purified antibody or a combination of 
antibodies at 50 Izg each in a final volume of 300 ~tl of PBS. Mice 
were killed 1-5 d after antibody injection as indicated per experi- 
ment, thymus and spleen were removed and disrupted into single 
cells, which were counted and analyzed by immunofluorescence. 
In the in vivo antibody cross-linking studies, animals were first 
injected with 50 btg biotinylated anti-CD27 mAb or hamster IgG. 
One d later, 50 p,g unconjugated anti-CD3 mAb (145.2C11)  as 
well as 50 p,g biotinylated anti-CD27 mAb or hamster lgG were 
injected,  followed  17-19  h  later by  50  b~g  streptavidin.  Mice 
were killed 3 d after injection with anti-CD3 mAb and cells were 
analyzed as described above. 
Immunqfluorescence Analysis.  Cell suspensions were washed in 
culture medium and seeded in 96-well round-bottom plates at 3 ￿ 
10  s cells per well. Fc receptors were blocked by incubation with 
2.4G2 mAb, cells were washed and incubated with the relevant 
antibodies, followed by second step reagents. In between incuba- 
tions, cells were washed in PBS with 0.5% BSA and 0.02%  so- 
dimn azide. For two parameter analysis, cells were incubated with 
FITC-conjugated anti-CD8 or anti-CD27  mAb and PE-conju- 
gated anti-CD4 or anti-CD25 mAb. For three parameter analysis, 
cells were incubated with biotinylated anti-CD4 and anti-el)8 
mAb,  PE-conjugated  anti-CD25  mAb  and  FITC-conjugated 
anti-CD27 mAb, followed by incubation with streptavidin-con- 
jugated Tricolor (Caltag, San Francisco, CA). Cells were analyzed 
on a FACScan  |  using Lysys software (Becton Dickinson, Moun- 
tain View, CA). Live cells were gated on the basis of forward and 
side scatter.  For analysis of the CD4-8-  thymocyte population, 
cells were gated on the basis of negative staining with Tricolor. 
Immunohistology.  Thymuses were derived from 6-I0-wk-old 
BALB/C  mice  and  frozen  tissue  sections  were  prepared  and 
stained as described (39) with FITC-conjugated anti-CD3 nLAb 
(500A2)  or anti-CD27 mAb. Micrographs were recorded with a 
Leitz Orthoplan, equipped with a Leitz Ploemopak illumination 
system, a  10(} W  HBO  mercury lamp and a ProbeMaster (Per- 
ceptive Scientific International,  Chester,  UK),  consisting of an 
Apple  Quadra  computer,  color  monitor,  cooled  CCD  24-bit 
camera,  GPIB  interface board,  optical disk,  and  a  microcope- 
adjusted fluorescent filter cube. 
Results 
CD27  Expression  Is  Upregulated  at the  Transition from  the 
CD44-,  CD25 + to the  CD44-,  CD25-  Pre-T Cell Stage. 
When  anti-CD27  mAb LG.3A10  was  used  for immuno- 
fluorescence analysis of frozen thymus sections, virtually all 
thymocytes in both cortex and medulla stained with equal 
676  CD27 Participates in Murine T Celt Development Figure 1.  Murine CD27 is uniformly expressed on all thymocytes 
with exception of some subcapsular cells. Frozen sections of murine 
thymus were stained with FITC-conjugated anti-CD27 mAb (b). To 
visualize the relative postion of cortex and medulla a serial section was 
stained with FITC conjugated anti-CD3~ mAb which primarily stains 
the medulla (a). Higher magnification of the subcapsular region of the 
thymus, stained with anti-CD27 mAb, is shown in c. 
intensity (Fig. 1 /3). The location of cortex and medulla was 
determined  by staining  of a  serial  section  with  anti-CD3 
mAb as shown in Fig.  1 A.  However,  a higher magnifica- 
tion  revealed  heterogeneity  in  CD27  expression  among 
subcapsular lymphoblasts in  the  thymic cortex.  While  the 
majority of cells at this location is clearly CD27 positive,  a 
minority expresses CD27 at low density or appears negative. 
Such cells occur in small foci under the capsule (Fig.  1 C). 
The  subcapsular  localization  of  CD27  l~  thymocytes 
suggested that these cells are recent thymic immigrants.  To 
investigate  whether  CD27  l~  and  CD27  high  thymocytes 
could be discriminated in terms of maturity,  we compared 
CD27  expression  levels  on  CD4-8-  thymocytes of wild- 
type  and  RAG-1 -/-  mutant  mice.  In  RAG-1 -/-  mice, 
differentiation  of CD4-8-  thymocytes  is  arrested  at  the 
CD44-,  CD25 +  stage.  In  wild-wpe  mice,  the  CD4-8- 
population  contains  a  significant  amount  of  CD44-, 
CD25- cells,  which result from pre-TCR-mediated differ- 
entiation  (2).  Immunofluorescence  analysis  indicated  that 
all  CD4-8-  thymocytes of RAG-1 -/-  mice  are  CD27  l~ 
(Fig.  2).  In wild-type mice,  the  CD4-8-  population  con- 
tains  not  only  these  CD27  l~  cells,  but  also  a  subset  of 
CD27  high cells  (Fig. 2).  Concomitant analysis of the expres- 
sion of CD44  (not shown)  and CD25  (Fig. 3),  allowed us 
to  define  the  CD27  hlgh population  as  CD44-,  CD25-. 
These results indicate that CD27  expression is upregulated 
upon  differentiation  of the  CD4-8-  population  from the 
CD44-, CD25 + to the CD44-, CD25- stage. Throughout 
subsequent  thymocyte  development,  CD27  remains  uni- 
formly expressed at this relatively high density (Fig. 2). 
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Figure 2.  Cell  surface expression of CD27 is upregulated on CD4-8~ 
thymocytes in wild type, but not in ILAG-I  /- nfice. Thymocyte sus- 
pensions of  wild-type (W73 and RAG-1 -/- mice were stained with anti- 
CD4-PE,  anti-CD8-biotin  plus streptavidin-conjugated Tricolor  and 
anti-CD27-F1TC mAb. CD27 staining (black) is compared to  staining 
with irrelevant F1TC-conjugated antibody (white). For analysis of wild- 
type total thymocytes and RAG-1-~-  thymocytes, all viable cells were 
gated. For  analysis of CD27  expression on  CD4-8-  wild-type thy- 
mocytes, cells were gated for lack of CD4 and CD8 expression. 
CD3  Signaling  Results  in  Increased  CD27  Expression  on 
CD4-8-Pre-TCells.  The  developmental  transition  of 
CD44-,  CD4-8-25 +  thymocytes  to  the  CD44-, 
CD4-B-25-  stage  is  controlled by the  pre-TCR  (5,  40). 
To investigate whether pre-TCR signaling may induce the 
upregulation  of CD27 expression, we used an in vivo thy- 
mocyte maturation  system.  It  has  been  shown  previously 
that injection of anti-CD3e mAb into 1KAG-t-/- mice in- 
duces the differentiation ofCD4-8-25 + thymocytes to the 
CD4+8+25 -  stage and an ~-~50-fold  increase in thymocyte 
numbers  (9,  10).  RAG-1 -/-  thymocytes express very low 
levels  of CD3  molecules  at  the  plasma  membrane.  Anti- 
CD3e  mAb binds  to these  molecules  and presumably in- 
duces  their  signaling  activity,  which  mimicks  the  normal 
function  of the  pre-TCR.  As  described  above,  CD4-8- 
thymocytes  of untreated  RAG-1 -/-  mice  are  uniformly 
CD27  [~  while the great majority expresses CD25 at high 
levels.  Anti-CD3  mAb treatment  gave rise  to  a  subset  of 
CD4-8-  cells  which were CD27  high and lacked CD25.  In 
fact, the staining profile of the RAG-1 -/-  CD4-8-  popu- 
lation  after  anti-CD3e  mAb treatment  was comparable  to 
that of wild-type CD4-8-  thymocytes (Fig. 3). This result is 
consistent with the notion that CD27 upregulation is part of 
the differentiation program inititated by pre-TCR signaling. 
Anti-CD27  mAb Inhibits CD3-mediated Pre-T Cell Expan- 
sion and Differentiation.  Since  expression  of CD27  increases 
at  the  transition  of CD4-8-25 +  cells  to  the  CD4+8+25 - 
stage,  we  were  interested  to  test  whether  CD27  exerts  a 
function at this point in thymocyte development. To assess 
whether CD27 plays a role in the expansion and/or differ- 
entiation ofCD4-8-25 + thymocytes induced by pre-TCR 
signaling,  we  again  made  use  of RAG-l -/-  mice.  The 
mice  were  injected  intravenously  with  anti-CD27  n~b 
alone, or combined with anti-CD3~ mAb. After 5 d, when 
precursor cells appeared to be maximally expanded to form 
the CD4+8 + compartment, the animals were sacrificed and 
the total number of thymocytes, as well as their differentia- 
tion state was determined.  As published previously (8-10), 
treatment ofIkAG-l-deficient thymocytes with anti-CD3e 
mAb reproducibly induced their expansion from a few mil- 
lion  to  about  100  ￿  106  cells  (Fig.  4  A).  Strikingly,  this 
effect of anti-CD3~ mAb was profoundly impeded by co- 
injection with anti-CD27, but not control hamster IgG an- 
tibody  (Fig.  4  A).  Injection of anti-CD27  mAb alone,  or 
control  hamster  lgG  did  not  affect  thymocyte  numbers 
(Fig. 4 A). 
The upper panel of Fig. 4 B shows that anti-CD3e mAb 
induced  the  generation  of the  CD4+8 +  thymocyte com- 
partment.  Co-injection  of anti-CD27  mAb  resulted  in  a 
specific decrease in the  absolute number of CD4+8 + cells, 
whereas the size of the CD4-8-  compartment was not af- 
fected.  Apparently,  anti-CD27  mAb  impedes  both  CD3- 
mediated  thymocyte  expansion  and  differentiation  to  the 
CD4+8 + stage.  The  effect on thymocyte differentiation  is 
also illustrated by the incomplete downregulation of CD25 
expression  in  mice  treated  with  a  combination  of anti- 
CI93e and anti-CD27  mAbs, as compared to mice treated 
with  anti-CD3~  mAb alone  (Fig.  4  B,  lower panel).  Anti- 
CD27 mAb interfered with the CD3-mediated downregu- 
lation of CD25 already in the first two days after antibody 
injection, before the generation of CD4+8 + cells  (data not 
shown).  In conclusion,  injection  of anti-CD27  mAb into 
RAG-1 -/- mice severely  impedes  the  CD3-mediated  ex- 
pansion  and  differentiation  of CD4-8-25 +  thymocytes to 
the CD4+8+25- stage. 
Anti-CD27 mAb Inhibits pre-T Celt Expansion in TCRol- l- 
Mice.  As shown above, pre-TC1L signaling does not take 
place  in  RAG-deficient  mice,  but  can  be  mimicked  by 
anti-CD3  mAb.  To  test the  effect of anti-CD27  mAb on 
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Figure  3.  CD27  l~  CD4-8  thymocytes are 
CD25+; mimicking the pre-TCR signal in RAG- 
1 /- mice induces differentiation of CD4  8- thy- 
mocytes  to  the  CD27  h~gh, CD25- stage￿9 Thy- 
mocyte  suspensions of  wild-type (W7) mice, 
RAG-I -/  mice and RAG-1 -/-  mice treated in 
vivo with 50 Ixg of anti-CD3 rnAb for 5 d, were 
stained with biotinylated anti-CD4 and anti-CD8 
mAbs plus streptavidin-conjugated Tricolor, anti- 
CD25-PE  and  anti-CD27-FITC.  The  CD4-8- 
population was gated on the basis of lack of Tri- 
color staining and analyzed for CD25 and CD27 
expression. 
normal  pre-TCR-regulated  thymic  development,  we 
made use ofTCRc~ -/- mice, which can form a pre-TCR, 
but not TCRotl3.  As a consequence,  CD4+8 + thymocytes 
develop normally,  but maturation  to the  CD4 +  or CD8 + 
single positive stage cannot take place (5,  41).  This experi- 
mental  system  ensures  that  injection  of anti-CD27  mAb 
does not influence  the  process of thymic selection,  which 
would complicate interpretation  of the results. 
TCRoL  -/-  mice  were  injected  with  anti-CD27  mAb 
and  analyzed at  1,  2,  and  3  d  after  injection.  Thymocyte 
numbers were reduced about three to fourfold after 3  d  of 
treatment  with anti-CD27  mAb,  whereas  control hamster 
IgG had no effect (Fig. 5). We did not observe an increase 
in the percentage  of CD25 + thymocytes upon anti-CD27 
mAb  treatment,  presumably  because  the  background  of 
CD4+8+25 -  cells  in  the  TCRc~ -/-  thymus  is  too  large. 
Therefore, we could not assess whether antibody treatment 
affected thymocyte differentiation.  However, it is clear that 
anti-CD27  mAb  treatment  impeded  normal  pre-TCR- 
driven thymocyte expansion. 
The Inhibition of CD3-mediated pre-T Cell Development by 
Anti-CD27 mAb Is Specific.  To address the question whether 
binding  of any  antibody,  irrespective  of its  specificity,  to 
the  developing  thymocytes would  exert  an  inhibitory  ef- 
fect,  the  experiments  outlined  above were  repeated  using 
the 5.9 mAb, which recognizes a Ly-6 like molecule.  Like 
anti-CD27  mAb,  5.9  mAb is  of Armenian hamster origin 
and binds to both CD4-8- and CD4+8 + thymocytes of  wild- 
type (Ossendorp,  F., unpublished observation), RAG-1-/- 
and TCR~x -/- mice (Fig. 6 A). 
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The 5.9 mAb was injected into RAG-1 -/-  mice,  either 
alone,  or in  combination with  anti-CD3  mAb and  its  ef- 
fects were compared with those of anti-CD27 mAb in the 
same experiment.  Three days after antibody injection, mice 
were sacrificed and thymocyte number and  differentiation 
stage  were  determined.  At  this  timepoint,  the  effects  of 
anti-CD3  mAb  on  thymocyte  development  are  not  yet 
maximal,  but  this  shorter  time  period  was  chosen  to  ex- 
clude differential effects of 5.9 and anti-CD27 mAbs due to 
a  possible  difference  in  antibody  half life.  In  contrast  to 
anti-CD27  mAb,  5.9  mAb  had  no  significant  effect  on 
CD3-mediated  thymocyte expansion  (Fig.  6  B),  or differ- 
entiation  (data not shown), while the antibody was present 
on the  cells  according to FACS  |  analysis.  In addition,  in- 
jection of 5.9 mAb in TCIZe~ -/  mice did not affect thy- 
mocyte  numbers  (data  not  shown).  We  conclude,  there- 
fore,  that  the  effects  of anti-CD27  mAb  on  thymocyte 
development  are  due  to  binding  of the  antibody  to  the 
CD27  molecule  and  cannot  be  attributed  to  non-specific 
(e.g.,  phagocytic) mechanisms activated by antibody coat- 
ing of the thymocytes. 
Cross-linking of Anti-CD27  mAb  In  Vivo Restores CD3- 
mediated Pre-T Cell Expansion  and Differentiation to  Normal 
Levels.  The  specific  inhibition  of  CD3-mediated  thy- 
mocyte development by anti-CD27 mAb can be explained 
in two ways: (a) the antibody induces CD27 receptor func- 
tion or (b) the antibody inhibits the naturally occurring in- 
teraction  between  CD27  and its  ligand  and  therewith  in- 
hibits  receptor  function.  In mature  T  cells,  the  LG.3A10 
mAb employed here can induce CD27 function, but only A  120 
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when  cross-linked by second step reagent  (29).  In our in 
vivo  system,  no  second  step  reagent  was  added,  but  we 
cannot  exclude  that  the  antibody was  cross-linked by Fc 
receptors present on thymic ceils.  Use of Fab fragments is 
not an option in this system, since their half life in vivo is 
very short.  It was decided to resolve this issue by compar- 
ing  the  effect of anti-CD27  mAb  alone  to  the  effect  of 
anti-CD27  mAb that was deliberately cross-linked by the 
addition of a second step reagent. 
RAG-1 -/-  mice were  injected  with  biotinylated  anti- 
CD27 or control antibody, followed by unconjugated anti- 
CD3 mAb. Subsequently, streptavidin was injected to cross- 
link the anti-CD27  mAb. 3  d  after injection  of anti-CD3 
mAb,  the  thymocyte  compartment  was  analyzed.  This 
proved optimal for reading  out  the  effects of biotinylated 
anti-CD27 mAb, which has a shorter half life in vivo than 
the unconjugated antibody. Like the unconjugated antibody, 
biotinylated anti-CD27 mAb inhibited the CD3-mediated 
increase in thymocyte numbers (Fig. 7 A). In contrast, upon 
cross-linking of anti-CD27  mAb with streptavidin,  no in- 
hibition  of the  CD3-induced  thymocyte  expansion  was 
observed.  Immunofluorescence  analysis  indicated  that  in 
both cases similar amounts of CD27 molecules were occu- 
pied by specific antibody, indicating that streptavidin-bind- 
ing did not affect the degree of receptor internalization (re- 
sults  not  shown).  Similarly,  cross-linked  anti-CD27  mAb 
did  not  affect CD3-induced  thymocyte differentiation,  as 
read out by downregulation of the CD25 molecule (Fig.  7 
/3). Apparently, induction of CD27 function by cross-link- 
ing of the receptor allows pre-T cell development to occur 
in response to anti-CD3e mAb. Therefore, we suggest that 
non-cross-linked  anti-CD27  mAb  inhibits  CD3-induced 
pre-T cell development by interfering with a naturally oc- 
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curring  receptor-ligand  interaction.  When  physiological 
CD27  receptor function is allowed to take place, or when 
it is induced  artificially with  cross-linked antibody,  CD3- 
mediated thymocyte proliferation and  differentiation pro- 
ceed normally. 
Discussion 
The most immature thymocytes in the mouse are con- 
tained within the CD4-8- population, which can be sub- 
divided  into  CD44+25 -,  CD44+25 +,  CD44-25 +,  and 
CD44-25-  subsets  of increasing  maturity  (1).  Functional 
TCIL~  gene  rearrangement  and  pT~  expression  (7,  42) 
first  occur.in  the  CD44-25 +  population,  allowing  pre- 
TCR  expression.  The  transition  from the  CD44-25 +  to 
the CD44-25- stage is dependent on the pre-TCtk, as ev- 
idenced by the phenotype of P,.AG- (2, 3), TCR[3- (5) and 
pT0t-(40) deficient mice. From our studies,  CD27 appears 
to be a very useful marker for thymocyte maturation in the 
mouse, since it is not expressed, or only at very low levels, 
on  the  CD44+25 -  and  CD44+25 +  populations,  but  it is 
found at high levels on the  CD44-25-  and more mature 
thymocyte populations.  In other words,  the  upregulation 
of CD27 cell surface levels coincides with the induction of 
pre-TCR expression (7, 42) and function. In fact, we have 
shown here that mimicking the pre-TCP,, signal in RAG- 
1 -/-  mice induces  the  upregulation  of CD27.  CD27  can 
be considered a differentiation marker in  the  murine sys- 
tem, since its expression remains high upon further thymic 
maturation to the CD4+8 + and the mature, single positive 
stages. 
In this paper, we have demonstrated that in the mouse, 
CD27  can  exert  a  function  at  the  transition  from  the 
CD44-25 +  stage  to  the  CD44-25-  stage, when  the pre- 
TCIk mediates further thymocyte development.  Injection 
of LG.3A10  anti-CD27  mAb  in  vivo  counteracted  pre- 
TClk-induced  thymocyte  differentiation  and  expansion. 
We have obtained similar results using fetal thymic organ 
cultures from RAG-1 -/-  mice: thymocyte expansion and 
differentiation  to  the  CD4+8 +  stage,  as  induced  by anti- 
CD3 mAb, was counteracted by anti-CD27 mAb. For the 
interpretation of its effect on thymocyte development, it is 
essential to know whether anti-CD27 mAb inhibits or in- 
duces CD27  function in these systems. We know that the 
LG.3A10  mAb  needs  to  be  cross-linked  to  exert  its  co- 
stimulatory  activity on  TCR.-activated  peripheral  T  cells 
(29),  in  line with  the  multimeric nature  of the ligands  of 
the TNF receptor family (11,  12).  In absence of cross-link- 
ing,  the antibody inhibits interaction  between  CD27  and 
human  CD70,  thus  abrogating  costimulatory  activity  (J. 
Nieland,  personal  communication).  Although  we  cannot 
assess whether the  LG.3A10  mAb was cross-linked by Fc 
receptors  in  vivo,  deliberate  cross-linking of the  biotiny- 
lated version of this antibody with streptavidin abrogated its 
inhibitory effect on CD3-mediated thymocyte differentia- 
tion  and expansion.  This implies that induction  of CD27 
function,  which  occurs  upon  cross-linking,  cannot  coun- 
teract the CD3 signal in RAG-1 -/- mice. Therefore, it is A  RAG- 1 -/-  TCR c~-/- 
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+  v,  Figure 6.  (A) The 5.9 mAb recognizes both CD4  8- and CD4+8  + 
thymocytes of RAG-1  /- and TCRe~ /- mice, Thymocytes of RAG- 
1  -/  mice  taken either before or after 5 d in vivo treament with anti- 
CD3 mAb, as well as TCR~t /- thymocytes were stained with FITC- 
conjugated 5.9 mAb (black), or with negative  control antibody (white). (B) 
The 5.9 mAb does not affect CD3-mediated thymocyte development. 
RAG-1-/- mice were injected with 5{) p,g of antibody  or combination  of 
antibodies  as indicated. 3 d later, the total nmnber of cells per thynms was 
determined. Shown are the means and standard deviations  of a representa- 
tive experiment  out of three experiments  peffonned in duplo. 
most likely that non-cross-linked anti-CD27 mAb blocks a 
physiological  CD27-1igand  interaction.  Our  experiments 
indicate that such an interaction contributes to CD3-medi- 
ated  thymic  development in  the  RAG-V/-  system  and 
pre-TCR-mediated thymic expansion in TCRoL -/-  mice. 
It remains to  be  established whether  CD27  signaling en- 
hances  thymocyte  expansion by increasing CD3-induced 
cell proliferation per se or by increasing cell survival. Since 
thymocytes appear  to  become very sensitive to  apoptotic 
stimuli  at  the  transition  from  the  CD44-25 +  to  the 
CD44+25 + differentiation stage  (43),  enhanced survival of 
these precursor cells is expected to contribute significantly 
to the size of the CD4+8 + population. 
Due to the lack of specific reagents, the expression of the 
CD27 ligand, CD70, has not yet been analyzed in the mu- 
vine system. CD70 has been detected on occasional stromal 
cells in the human thymus (44). Therefore, it is conceivable 
that physiological CD27-CD70 interactions take place dur- 
ing thymic T  cell development. However, findings in the 
human system cannot easily be extrapolated to the murine 
system, since CD27 protein expression is regulated differ- 
ently in both species. In human, CD27 is found primarily 
on mature,  medullary thymocytes  (26,  45).  CD27  is  not 
detectable on CD4+8 + cortical thymocytes in situ, but in- 
ducible in vitro by TCR-mediated activation (45).  Also, 
CD27  expression on peripheral T  cells is regulated differ- 
ently in both species: in the mouse, CD27 cell surface lev- 
els  are relatively high on resting T  cells and increase only 
moderately upon  TCR-mediated activation (29  and data 
not shown),  whereas  in human, CD27  levels are  low  on 
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Figure  7.  (A)  Cross-linking  of 
anti-CD27  mAb  in  vivo restores 
CD3-mediated  pre-T  cell  expan- 
sion.  RAG-1  /-  mice  were  pre- 
treated with 50  ~g of biotinylated 
anti-CD27  mAb or control ham- 
ster  IgG.  1  d  later,  50  p~g  anti- 
CD3r  mAb was  injected with an 
additional  dose  of  biotinylated 
anti-CD27  mAb or control ham- 
ster IgG, followed 17-19 h later by 
injection of 50 Ixg of streptavidin. 
3  d  after  injection of anti-CD3~ 
mAb,  total  number  of  cells  per 
thymus was determined. Shown are 
the means and standard deviations 
of two  independent  experiments. 
(/3)  Cross-linking  of  anti-CD27 
mAb in vivo restores CD3-medi- 
ated  pre-T  cell  differentiation. 
RAG-l-/-  mice  were  treated 
with biotinylated  anti-CD27 mAb 
or control  hamster IgG  and cross- 
linked with streptavidin as outlined 
in A. 3 d after anti-CD3r mAb in- 
jection,  thymocytes  were  stained 
with anti-CD25-PE (black) or PE- 
conjugated  negative  control  anti- 
body (white). 
resting T  cells and transiently  increase  about  fivefold upon 
TCR-mediated  cellular activation  (26).  These  data  can be 
reconciled by the  statement  that  once induced,  CD27  ex- 
pression  in  the  mouse  is  of a  rather  constitutive  nature, 
while  its  expression  in  the  human  system  is  more  pro- 
nouncedly  subject  to  TCR-mediated  regulation.  There- 
fore, it cannot be excluded that  in the human  thymus,  the 
pre-TCR  induces  CD27  expression  on  the  small  transi- 
tional  population  that  generates  the  CD4+8 +  compart- 
ment. 
According  to  the  data  presented  in  this  paper,  CD27 
would  cooperate  with  the  pre-TCR  in  mediating  thy- 
mocyte differentiation and expansion,  as it cooperates with 
the TCR  in mediating peripheral T  cell differentiation and 
expansion  (26,  29,  32).  We  are  currently  testing  this  hy- 
pothesis by the generation of CD27 -/-  mutant mice. 
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